Cerebrolysin® protects isolated cortical neurons from neurodegeneration after brief histotoxic hypoxia

  • B. Hutter-Paier
  • E. Steiner
  • M. Windisch
Part of the Journal of Neural Transmission. Supplementa book series (NEURAL SUPPL, volume 53)


A brief period of histotoxic hypoxia exhibits certain metabolic features resembling the in vivo situation of ischemia. In this study the neuroprotective effects of the peptidergic nootropic drug Cerebrolysin® (Cere) against iodoacetate induced histotoxic hypoxia were investigated. For that purpose isolated cortical neurons from 9 day chicken embryos were pre-cultured with 0 to 6.4mg.Cere/ml medium. At the 8th day in vitro histotoxic hypoxia was induced by incubation with 0.01 or 0.1mM iodoacetate. Cells were allowed to recover from toxic stress for 3, 6, 24 or 48 hours. Cere protected neurons dose dependently from delayed neuronal cell death due to 0.01 mM iodoacetate even after a recovery period of 48 h. After induction of histotoxic hypoxia by 0.1 mM iodoacetate high concentrations of Cere again led to neuronal protection after the 3 and 6 h recovery period. Moreover the influence of Cere on the cytoskeletal protein MAP2 in neurons submitted to 0.01 mM iodoacetate was investigated. With Western blotting and immuno-histochemical techniques it has been demonstrated that the drug clearly increased MAP2 abundance after histotoxic hypoxia. The present study points out that after severe damage of cortical neurons with iodoacetate Cere is able to protect neurons from delayed neuronal cell death maybe by maintaining neuronal plasticity due to avoidance of the cytoskeletal breakdown.


Cortical Neuron Neuronal Cell Death Cereb Blood Flow Toxic Stress MAP2 Abundance 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Baird A (1987) Distribution of fibroblast growth factors (FGF’s) in tissue and structure-function studies with synthetic fragments of basic FGF. J Cell Physiol 5: 101–106CrossRefGoogle Scholar
  2. Bartus RT, Dean RL, Cavanaugh K, Eveleth D, Carriero DL, Lynch G (1995) Time-related neuronal changes following middle cerebral artery occlusion: implications for therapeutic intervention and the role of calpain. J Cereb Blood Flow Metab 15: 969–979PubMedCrossRefGoogle Scholar
  3. Bickler PE, Buck LT, Hansen BM (1994) Effects of isoflurane and hypothermia on glutamate receptor-mediated calcium influx in brain slice. Anesthesiology 81(6): 1461–1469PubMedCrossRefGoogle Scholar
  4. Boniece RI, Wagner JA (1993) Growth factors protect PC 12 cells against ischemia by a mechanism that is independent of PKA, PKC, and protein synthesis. J Neurosci 13(10): 4220–4228PubMedGoogle Scholar
  5. Caceres A, Mautino J, Kosik KS (1992) Suppression of MAP2 in cultured cerebellar macroneurons inhibits minor neurite formation. Neuron 9: 607–618PubMedCrossRefGoogle Scholar
  6. Cuevas P, Carceller F, Gimenez-Gallego G (1994) Fibroblast growth factor and cerebral ischaemia. Neurol Res 16: 181–183PubMedGoogle Scholar
  7. Djuricic B, Berger R, Paschen W (1994) Protein synthesis and energy metabolism in hippocampal slices during extended (24 hours) recovery following different periods of ischemia. Metab Brain Dis 9: 377–389PubMedCrossRefGoogle Scholar
  8. Dux E, Oschlies U, Wiessner C, Hossmann K-A (1992) Glutamate-induced ribosomal disaggregation and ultrastructural changes in rat cortical neuronal culture: protective effect of horse serum. Neurosci Lett 141: 173–176PubMedCrossRefGoogle Scholar
  9. Dux E, Oschlies U, Uto A, Kusumoto M, Hossmann K-A (1996) Early ultrastructural changes after brief histotoxic hypoxia in cultured cortical and hippocampal CA1 neurons. Acta Neuropathol 92: 541–544PubMedCrossRefGoogle Scholar
  10. Ferrari R, Ceconi C, Curello S, Cargnoni A, Alfieri O, Pardini A, Marzollo P, Visioli O (1991) Oxygen free radicals and myocardial damage: protective role of thiol-containing agents. Am J Med 91: 95S–105SPubMedCrossRefGoogle Scholar
  11. Ferreira IL, Duarte Cerebrolysin B, Carvalho AP (1997) Chemical ischemia in cultured retina cells: role of excitatory amino acid receptors and of energy levels on cell death. Brain Res 768: 157–166PubMedCrossRefGoogle Scholar
  12. Gage FH, Tuszynski MH, Chen KS, Fagan AM, Higgins GA (1991) Nerve growth factor function in the central nervous system. Curr Top Microbiol Immunol 165: 71–93PubMedCrossRefGoogle Scholar
  13. Gschanes A, Valouskova V, Windisch M (1997) Ameliorative influence of a nootropic drug on motor activity of rats after bilateral carotid artery occlusion. J Neural Transm 104: 1319–1327PubMedCrossRefGoogle Scholar
  14. Hollmann M, Heinemann S (1994) Cloned glutamate receptors. Annu Rev Neurosci 17: 31–108PubMedCrossRefGoogle Scholar
  15. Holtzman DM, Sheldon RA, Jaffe W, Cheng Y, Ferriero DM (1996) Nerve growth factor protects the neonatal brain against hypoxic-ischemic injury. Ann Neurol 39: 114–122PubMedCrossRefGoogle Scholar
  16. Hossmann K-A (1994) Glutamate-mediated injury in focal cerebral ischemia: the excitotoxin hypothesis revised. Brain Pathol 4: 23–36PubMedCrossRefGoogle Scholar
  17. Hutter B, Grygar E, Windisch M (1996) Death of cultured telencephalon neurons induced by glutamate is reduced by the peptide derivative Cerebrolysin. J Neural Transm 47: 267–273CrossRefGoogle Scholar
  18. Kitagawa K, Matsumoto M, Ninobe M, Mikoshiba K, Hata R, Ueda H, Handa N, Fukunaga R, Isaka Y, Kimura K, Kamada T (1989) Microtubule-associated protein 2 as a sensitive marker for cerebral ischemic damage — immunohistochemical investigation of dendritic damage. Neurosciences 31: 401–411CrossRefGoogle Scholar
  19. Koroleva VI, Korolev OS, Loseva E, Bures J (1998) The effect of MK-801 and of brain derived polypeptides on the development of focal brain ischemia induced by photothrombotic occlusion of the distal middle cerebral artery in rats. Brain Res (in press)Google Scholar
  20. Kusumoto M, Dux E, Hossmann KA (1997) Effect of trophic factors on delayed neuronal death induced by in vitro ischemia in cultivated hippocampal and cortical neurons. Metab Brain Dis 12: 113–120PubMedGoogle Scholar
  21. Lewis SA, Ivanov IE, Lee GH, Cowan NJ (1989) Organization of microtubules in dendrites and axons is determined by a short hydrophobic zipper in microtubule-associated proteins MAP2 and tau. Nature 342: 498–505PubMedCrossRefGoogle Scholar
  22. Lindsay MR, Wiegand JST, Altar A, Distefano PS (1994) Neurotrophic factors: from molecule to man. TINS 17/5: 182–190Google Scholar
  23. Lipton SA, Rosenberg PA (1994) Excitatory amino acid as a final common pathway for neurologic disorders. N Engl J Med 330: 613–622PubMedCrossRefGoogle Scholar
  24. Maiese K, Boniece I, Demeo D, Wagner AJ (1993) Peptide growth factors protect against ischemia in culture by preventing nitric oxide toxicity. J Neurosci 13/7: 3034–3040Google Scholar
  25. Maiese K, Wagner AJ, Boccone L (1994) Nitric oxide: a downstream mediator of calcium toxicity in the ischemic cascade. Neurosci Lett 166: 43–47PubMedCrossRefGoogle Scholar
  26. Matthews RT, Ferrante RJ, Jenkins BG, Browne SE, Goetz K, Berger S, Chen IY, Beal MF (1997) Iodoacetate produces striatal excitotoxic lesions. J Neurochem 69(1): 285–289PubMedCrossRefGoogle Scholar
  27. Mattson MP, Kater SB (1989) Excitatory and inhibitory neurotransmitters in the generation and degeneration of hippocampal neuroachitecture. Brain Res 478: 337–348PubMedCrossRefGoogle Scholar
  28. Mattson MP, Cheng B (1993) Growth factors protect neurons against excitotoxic/ischemic damage by stabilizing calcium homeostasis. Stroke 24: 136–140Google Scholar
  29. McCay PB, King MM (1980) Vitamin E: its role as a biologic free radical scavenger and its relationship to the microsomal mixed-function oxidase system. In: Machlin LJ (ed) Vitamin E. A comprehensive treatise. Marcel Dekker, New York, pp 289–317Google Scholar
  30. Meldrum BS (1990) Protection against ischemic neuronal damage by drugs acting on excitatory neurotransmission. Cerebrovasc Brain Metab Rev 2: 27–57PubMedGoogle Scholar
  31. Mies G, Paschen W, Hossmann K-A (1990) Cerebral blood flow, glucose utilization, regional glucose and ATP content during the maturation period of delayed ischemic injury in gerbil brain. J Cereb Blood Flow Metab 10: 638–645PubMedCrossRefGoogle Scholar
  32. Mosmann T (1983) Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods 65: 55–63PubMedCrossRefGoogle Scholar
  33. Nicholls DG, Atwell D (1994) The release and uptake of excitators amino acids. Trends Pharmacol Sci 11: 462–468CrossRefGoogle Scholar
  34. Nozaki K, Finklestein SP, Beal MF (1993) Basic fibroblast growth factor protects against hypoxia-ischemia and NMDA neurotoxicity in neonatal rats. J Cereb Blood Flow Metab 13: 221–228PubMedCrossRefGoogle Scholar
  35. Olney JW (1993) Role of excitotoxins in developmental neuropathology. APMIS 40/101: 103–112Google Scholar
  36. Otto D, Unsicker K (1990) Basic FGF reverse chemical and morphological deficits in the nigrostriatal system of MPTP-treated mice. J Neurosci 10: 1912–1920PubMedGoogle Scholar
  37. Pettmann B, Louis JC, Sensenbrenner M (1979) Morphological and biochemical maturation of neurones cultured in the absence of glial cells. Nature 281: 378–380PubMedCrossRefGoogle Scholar
  38. Piswanger A, Paier B, Windisch M (1990) Modulation of protein synthesis in a cell-free system from rat brain by Cerebrolysin during development and aging. Amino Acids 3: 651–657CrossRefGoogle Scholar
  39. Pulsinelli AW, Brierley JB, Plum F (1982) Temporal profile of neuronal damage in a model of transient forebrain ischemia. Ann Neurol 11: 491–498PubMedCrossRefGoogle Scholar
  40. Ray P, Monroe FL, Berman JD, Fiedler J (1991) Cyanide sensitive and insensitive bioenergetics in a clonal neuroblastoma X glioma hybrid cell line. Neurochem 16: 1121–1124CrossRefGoogle Scholar
  41. Reiner PB, Laycock AG, Doll CJ (1990) A pharmacological model of ischemia in the hippocampal slice. Neurosci Lett 119(2): 175–178PubMedCrossRefGoogle Scholar
  42. Schwab M, Schaller R, Bauer R, Zwiener U (1997) Morphological effects of moderate forebrain ischemia combined with short-term hypoxia in rats — protective effects of Cerebrolysin. Exp Toxicol Pathol 49: 29–37PubMedCrossRefGoogle Scholar
  43. Schwab M, Bauer R, Zwiener U (1997b) Physiological effects and brain protection by hypothermia and Cerebrolysin after moderate forebrain ischemia in rats. Exp Toxicol Pathol 49: 105–116PubMedCrossRefGoogle Scholar
  44. Shoeman RL, Traub P (1990) Calpains and the cytoskeleton. In: Mellgren RL, Murachi T (eds) Intracellular calcium-dependent proteolysis. Raven Press, New York, pp 191–209Google Scholar
  45. Siman R, Noszek JC (1988) Excitatory amino acids activate calpain I and induce structural protein breakdown in vivo. Neuron 1: 279–287PubMedCrossRefGoogle Scholar
  46. Sugita Y, Kondo T, Kanazawa A, Itou T, Mizuno Y (1993) Protective effect of FPF 1070 (cerebrolysin) on delayed neuronal death in the gerbil — detection of hyroxyl radicals with salicylic acid. No To Shinkei 45: 325–331PubMedGoogle Scholar
  47. Uto A, Dux E, Kusumoto M, Hossmann K-A (1995) Delayed neuronal death after brief histotoxic hypoxia in vitro. J Neurochem 64: 2185–2192PubMedCrossRefGoogle Scholar
  48. Verity MA (1991) Use and abuse of tissue culture in neurotoxicity studies. Neurotoxicology 12: 457–459PubMedGoogle Scholar
  49. White BC, Krause GS, O’Neil BJ, Degrada DJ, Tiffany BR, Grossman LI, Grunberger G (1993) Potential role of growth factors in global brain ischemia and reperfusion. The role of insulin-like growth factors in the nervous system. Brain Res 692: 281–283Google Scholar
  50. Windisch M, Piswanger A (1985) Beeinflussung des oxidativen Stoffwechsels von Hirn-, Leber-und Herzmuskelhomogenaten durch Peptidderivate und Kälberblutdialysat in vitro. Arzneimittelforschung/Drug Res 35: 87–89Google Scholar
  51. Windisch M, Paier B, Eggenreich U (1994) Neuronal growth factors and their role in degenerative brain diseases: a mini-review. Neurol Croat 43/2: 9–20Google Scholar
  52. Zeevalk GD, Nicklas WJ (1997) Contribution of glial metabolism to neuronal damage caused by partial inhibition of energy metabolism in retina. Exp Eye Res 65(3): 397–405PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Wien 1998

Authors and Affiliations

  • B. Hutter-Paier
    • 1
  • E. Steiner
    • 1
  • M. Windisch
    • 1
  1. 1.Institute of Experimental PharmacologyResearch Initiative EbeweGrazAustria

Personalised recommendations